What PharmaCyte Biotech Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 6 |
| Sells | 0 | 0 |
| Total trades | 0 | 16 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,035,000 |
| Disposed | 0 | 393,750 |
| Net activity | +0 | +641,250 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Schechter Jonathan | Director | Jan 07 | Open-market buy · P | +20,000 | $0.84 | +$16.9K | 192,500 |
| Silverman Joshua | CEO and President | Jan 07 | Open-market buy · P | +40,000 | $0.83 | +$33.3K | 416,250 |
| Schechter Jonathan | Director | Jan 06 | Open-market buy · P | +20,000 | $0.79 | +$15.8K | 172,500 |
| Silverman Joshua | CEO and President | Jan 06 | Open-market buy · P | +30,000 | $0.79 | +$23.7K | 376,250 |
| Schechter Jonathan | Director | Jan 05 | Open-market buy · P | +20,000 | $0.78 | +$15.6K | 152,500 |
| Silverman Joshua | CEO and President | Jan 05 | Open-market buy · P | +30,000 | $0.78 | +$23.5K | 346,250 |
| Abecassis Michael M | Director | Dec 12 | Withheld — tax / exercise cost · F | −16,875 | $1.02 | −$17.2K | 22,292 |
| Abecassis Michael M | Director | Dec 12 | Grant / award · A | +37,500 | — | — | 39,167 |
| Weinstein Robert | Director | Dec 12 | Withheld — tax / exercise cost · F | −33,750 | $1.02 | −$34.4K | 41,250 |
| Weinstein Robert | Director | Dec 12 | Grant / award · A | +75,000 | — | — | 75,000 |
| Schechter Jonathan | Director | Dec 12 | Withheld — tax / exercise cost · F | −67,500 | $1.02 | −$68.9K | 132,500 |
| Schechter Jonathan | Director | Dec 12 | Grant / award · A | +150,000 | — | — | 200,000 |
| Walker Wayne Remell | Director | Dec 12 | Withheld — tax / exercise cost · F | −16,875 | $1.02 | −$17.2K | 20,625 |
| Walker Wayne Remell | Director | Dec 12 | Grant / award · A | +37,500 | — | — | 37,500 |
| Silverman Joshua | CEO and President | Dec 12 | Withheld — tax / exercise cost · F | −258,750 | $1.02 | −$264K | 316,250 |
| Silverman Joshua | CEO and President | Dec 12 | Grant / award · A | +575,000 | — | — | 575,000 |
Loading...
